Human Menopausal Gonadotropins

PreclinicalSmall molecule

MMiao benyu

Human Menopausal Gonadotropins is one of 4 small molecule programs targeting IVF. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

IVFUnknown status

IVFPreclinical

Unknown status

Competition

Competitive Landscape

3 competitors in IVF

#DrugCompanyPhaseTrials

Ubiquinol

WWeill Medical College of Cornell University

Phase 2

—2

Ubiquinone

MMinneapolis Veterans Affairs Medical Center

Gnrh-a

1 4

Human Menopausal Gonadotropins

MMiao benyu

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

IVF1 trial

Effects of SNP of GnRH Receptor Genes in IVF Patients

Unknown status·MMiao benyu·N/A·NCT02979886·1,500 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Human Menopausal Gonadotropins. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Human Menopausal Gonadotropins compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Human Menopausal Gonadotropins. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Miao benyu company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: MMiao benyu

Human Menopausal Gonadotropins

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

IVF1 trial

References

Drug Info

Quick Facts

Related News